BioPharma Dive102d agoneutral
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investing.com102d agobullish
Biogen Q2 revenue, adjusted EPS beat estimates as growth portfolio lifts salesBarrons.com102d agoneutral
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster DrugsStockStory103d agoneutral
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of EarningsInvesting.com117d agobearish
Biogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradoxInvesting.com118d agobullish
Truist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key dataBarrons.com118d agobullish
Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details